Cardiovascular Risk Assessment

ACC GUIDELINES Apps brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, Enjoy!

Issue link:

Contents of this Issue


Page 2 of 5

Diagnosis Diagnosis Table 1. Recommendations for Risk Assessment Recommendations ACC/AHA COR ACC/AHA LOE e race- and sex-specific Pooled Cohort Equations a to predict 10-year risk for a first hard ASCVD event should be used in non- Hispanic African Americans and non-Hispanic Whites, 40-79 years of age. I B Use of the sex-specific Pooled Cohort Equations for non- Hispanic Whites may be considered when estimating risk in patients from populations other than African Americans and non-Hispanic Whites. IIb C If, aer quantitative risk assessment, a risk-based treatment decision is uncertain, assessment of 1 or more of the following— family history, hs-CRP, CAC score, or ABI—may be considered to inform treatment decision making. (See Table 2) IIb b B e contribution of ApoB, CKD, albuminuria, and cardiorespiratory fitness to risk assessment for a first ASCVD event is uncertain at present. N/A N/A Routine measurement of CIMT is not recommended in clinical practice for risk assessment for a first ASCVD event. III: No Benefit b B It is reasonable to assess traditional ASCVD risk factors c every 4-6 years in adults 20-79 years of age who are free from ASCVD and to estimate 10-year ASCVD risk every 4-6 years in adults 40-79 years of age who are free from ASCVD. IIa B Assessing 30-year or lifetime ASCVD risk based on traditional risk factors c may be considered in adults 20-59 years of age who are free from ASCVD and are not at high short-term risk. IIb C a Derived from the Atherosclerosis Risk in Communities (ARIC) study, Cardiovascular Health Study (CHS), Coronary Artery Risk Development in Young Adults (CARDIA) study, Framingham original and offspring cohorts. b Based on new evidence reviewed during ACC/AHA update of evidence. c Age, sex, total cholesterol, high-density lipoprotein cholesterol, systolic BP, use of antihypertensive therapy, diabetes, and current smoking.

Articles in this issue

Archives of this issue

view archives of ACC GUIDELINES Bundle - Cardiovascular Risk Assessment